Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors.
The chemokines and their receptors have been receiving exceptional attention in recent years following the discoveries that some chemokines could specifically block human immunodeficiency virus type 1 (HIV-1) infection and that certain chemokine receptors were the long-sought coreceptors which, along with CD4, are required for the productive entry of HIV-1 and HIV-2 isolates. Several chemokine receptors or orphan chemokine receptor-like molecules can support the entry of various viral strains, but the clinical significance of the CXCR4 and CCR5 coreceptors appear to overshadow a critical role for any of the other coreceptors and all HIV-1 and HIV-2 strains best employ one or both of these coreceptors. Binding of the HIV-1 envelope glycoprotein gp120 subunit to CD4 and/or an appropriate chemokine receptor triggers conformational changes in the envelope glycoprotein oligomer that allow it to facilitate the fusion of the viral and host cell membranes. During these interactions, gp120 appears to be capable of inducing a variety of signaling events, all of which are still not defined in detail. In addition, the more recently observed dichotomous effects, of both inhibition and enhancement, that chemokines and their receptor signaling events elicit on the HIV-1 entry and replication processes has once again highlighted the intricate and complex balance of factors that govern the pathogenic process. Here, we will review and discuss these new observations summarizing the potential significance these processes may have in HIV-1 infection. Understanding the complexities and significance of the signaling processes that the chemokines and viral products induce may substantially enhance our understanding of HIV-1 pathogenesis, and perhaps facilitate the discovery of new ways for the prevention and treatment of HIV-1 disease.
Stantchev
T S
TS
Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA. tstanchev@mxb.usuhs.mil
Broder
C C
CC
D001667:Binding, Competitive; D015704:CD4 Antigens / Q000378:metabolism; D018925:Chemokines / Q000378:metabolism*; D015696:Gene Products, tat / Q000378:metabolism; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D015497:HIV-1 / Q000378:metabolism*; D020962:Heterotrimeric GTP-Binding Proteins / Q000378:metabolism; D006801:Humans; D019707:Receptors, Chemokine / Q000378:metabolism*; D015728:Receptors, HIV / Q000378:metabolism*; D015398:Signal Transduction; D014779:Virus Replication; D054322:tat Gene Products, Human Immunodeficiency Virus
D015704:CD4 Antigens; D018925:Chemokines; D015696:Gene Products, tat; D015699:HIV Envelope Protein gp120; D019707:Receptors, Chemokine; D015728:Receptors, HIV; D054322:tat Gene Products, Human Immunodeficiency Virus; D020962:Heterotrimeric GTP-Binding Proteins